{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:13:02Z","timestamp":1790007182453,"version":"4.0.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Primary cervical malignant melanoma (MM) is an extremely rare tumor, and we are only aware of 44 reported cases. Further information is needed with regard to this disease\u2019s clinicopathologic features. Two patients (55 and 81\u2009yr old) with postmenopausal vaginal bleeding were diagnosed with primary cervical MM on the basis of hematoxylin-eosin staining and immunohistochemistry findings. Our literature review revealed that the average age in cases of primary cervical MM was 59\u2009yr (range, 34\u201381\u2009yr); 93% of patients presented with vaginal bleeding, and 82% of patients were diagnosed at an early clinical stage (International Federation of Gynecology and Obstetrics stages I\u2013II). Primary cervical MM is an extremely rare cervical tumor and is associated with a poor prognosis. Histologic morphology and immunohistochemistry are very important considerations for diagnosing this disease, which must be differentiated from cervical undifferentiated carcinoma, leiomyosarcoma, and malignant peripheral schwannoma.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000480","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T21:25:33Z","timestamp":1519334733000},"page":"196-203","source":"Crossref","is-referenced-by-count":14,"title":["Primary Cervical Malignant Melanoma: 2 Cases and a Literature Review"],"prefix":"10.1097","volume":"38","author":[{"given":"Can","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3322\/canjclin.48.1.6","article-title":"Cancer statistics, 1998","volume":"48","author":"Landis","year":"1998","journal-title":"CA Cancer J Clin"},{"key":"R2-20230824","first-page":"60","article-title":"Melanocarcinoma of the cervix uteri and vaginal vault","volume":"38","author":"Taylor","year":"1944","journal-title":"Arch Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the US","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"key":"R4-20230824","first-page":"82","article-title":"Blue nevus of the endocervix","volume":"25","author":"Cid","year":"1960","journal-title":"Anales de cirugi\u0301a"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1068-607X(98)00052-3","article-title":"Primary malignant melanoma of the uterine cervix: case report and review of the literature","volume":"5","author":"Cantuaria","year":"1998","journal-title":"Prim Care Update Ob\/Gyns"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2559.2000.00894.x","article-title":"Morphological and immunophenotypic variations in malignant melanoma","volume":"36","author":"Banerjee","year":"2000","journal-title":"Histopathology"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2559.1993.tb00474.x","article-title":"An immunophenotypic survey of malignant melanomas","volume":"23","author":"Bishop","year":"1993","journal-title":"Histopathology"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"73162","DOI":"10.18632\/oncotarget.17183","article-title":"Primary malignant melanoma of the cervix: report of 14 cases and review of literature","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1470-2045(08)70254-7","article-title":"Management of primary melanoma of the female urogenital tract","volume":"9","author":"Piura","year":"2008","journal-title":"Lancet Oncol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CCO.0b013e32830b0dda","article-title":"Management of melanomas of the female genital tract","volume":"20","author":"Sugiyama","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-0190","article-title":"Systematic review of medical treatment in melanoma: current status and future prospects","volume":"16","author":"Garbe","year":"2011","journal-title":"Oncologist"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/annonc\/mdl007","article-title":"Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma","volume":"17","author":"Bajetta","year":"2006","journal-title":"Ann Oncol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.critrevonc.2011.03.008","article-title":"A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer","volume":"81","author":"Pusceddu","year":"2012","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13224-013-0437-8","article-title":"Primary malignant melanoma of uterine cervix","volume":"64","author":"Bhargava","year":"2014","journal-title":"J Obstet Gynaecol India"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201903000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:39:57Z","timestamp":1692841197000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201903000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000480","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}